Quick Answer
AGIOS PHARMACEUTICALS, INC. reported Total Assets of $1.30 billion for fiscal year 2025.
AGIOS PHARMACEUTICALS, INC. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $1.30B | -22.0% |
| 2024 | $1.66B | +77.5% |
| 2023 | $937.12M | -24.3% |
| 2022 | $1.24B | -13.8% |
| 2021 | $1.44B | +68.6% |
| 2020 | $852.95M | -4.2% |
| 2019 | $890.74M | +3.8% |
| 2018 | $858.46M | +39.7% |
| 2017 | $614.40M | -0.8% |
| 2016 | $619.09M | +47.4% |
| 2015 | $420.06M | -14.6% |
| 2014 | $491.90M | +144.5% |
| 2013 | $201.21M | +46.9% |
| 2012 | $137.01M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.39B | -22.7% | -5.8% |
| June 30, 2025 | $1.47B | +90.3% | -5.4% |
| March 31, 2025 | $1.56B | +83.1% | -6.5% |
| December 31, 2024 | $1.66B | +77.5% | -7.2% |
| September 30, 2024 | $1.79B | +77.9% | +131.8% |
| June 30, 2024 | $773.06M | -28.8% | -9.0% |
| March 31, 2024 | $849.71M | -26.2% | -9.3% |
| December 31, 2023 | $937.12M | -24.3% | -7.0% |
- AGIOS PHARMACEUTICALS, INC. showed a decrease of -22.0% in Total Assets compared to the prior fiscal year.
- Over the 2012–2025 period, AGIOS PHARMACEUTICALS, INC.’s total assets has grown by 846.8% (from $137.01 million to $1.30 billion).
- The most recent figure is from AGIOS PHARMACEUTICALS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: